Oxbow Advisors LLC Makes New Investment in HealthEquity, Inc. $HQY

Oxbow Advisors LLC purchased a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the 2nd quarter, Holdings Channel reports. The fund purchased 37,990 shares of the company’s stock, valued at approximately $3,431,000.

Several other large investors have also modified their holdings of the business. Sivia Capital Partners LLC purchased a new position in shares of HealthEquity during the 2nd quarter worth approximately $306,000. Arrowstreet Capital Limited Partnership purchased a new stake in HealthEquity in the 2nd quarter valued at approximately $4,747,000. Marshall Wace LLP purchased a new stake in HealthEquity in the 2nd quarter valued at approximately $5,483,000. Amundi grew its holdings in HealthEquity by 9.3% during the 2nd quarter. Amundi now owns 30,203 shares of the company’s stock valued at $3,059,000 after buying an additional 2,574 shares during the last quarter. Finally, Jump Financial LLC acquired a new stake in HealthEquity during the 2nd quarter valued at $449,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HealthEquity

In other news, EVP Delano Ladd sold 7,500 shares of the company’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the transaction, the executive vice president owned 91,141 shares of the company’s stock, valued at $8,202,690. This represents a 7.60% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the transaction, the director owned 19,733 shares in the company, valued at approximately $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 17,905 shares of company stock worth $1,651,280. 1.60% of the stock is currently owned by insiders.

HealthEquity Stock Up 0.4%

HQY stock opened at $102.79 on Wednesday. The stock has a market capitalization of $8.59 billion, a P/E ratio of 38.50, a PEG ratio of 1.76 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $107.62. The company has a 50 day moving average price of $95.71 and a two-hundred day moving average price of $86.80.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. The company’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, sell-side analysts expect that HealthEquity, Inc. will post 3.92 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on HQY. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. BTIG Research increased their price objective on HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Friday, July 24th. Barrington Research reiterated an “outperform” rating and set a $110.00 price objective on shares of HealthEquity in a research report on Friday, May 22nd. Royal Bank Of Canada lifted their price objective on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research report on Wednesday, June 3rd. Finally, Wall Street Zen downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Eleven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and an average target price of $110.93.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.